It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The γ-aminobutyric acid type B (GABAB) receptor is a prototypical family C G protein-coupled receptor (GPCR) that plays a key role in the regulation of synaptic transmission. Although growing evidence suggests that GPCR signaling in neurons might be highly organized in time and space, limited information is available about the mechanisms controlling the nanoscale organization of GABAB receptors and other GPCRs on the neuronal plasma membrane. Using a combination of biochemical assays in vitro, single-particle tracking, and super-resolution microscopy, we provide evidence that the spatial organization and diffusion of GABAB receptors on the plasma membrane are governed by dynamic interactions with filamin A, which tethers the receptors to sub-cortical actin filaments. We further show that GABAB receptors are located together with filamin A in small nanodomains in hippocampal neurons. These interactions are mediated by the first intracellular loop of the GABAB1 subunit and modulate the kinetics of Gαi protein activation in response to GABA stimulation.
GABAB receptors mediate the effects of the main inhibitory neurotransmitter in the brain. Here, authors identify the cytoskeletal protein filamin A as a key player that controls the exact location and function of GABAB receptors at the cell surface.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of Würzburg, Institute for Pharmacology and Toxicology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Würzburg, Bio-Imaging Center/Rudolf Virchow Center, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); CNRS UMR5297, University of Bordeaux, Interdisciplinary Institute for Neuroscience (IINS), Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X)
2 University of Würzburg, Institute for Pharmacology and Toxicology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Würzburg, Bio-Imaging Center/Rudolf Virchow Center, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
3 University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); Universities of Birmingham and Nottingham, Centre of Membrane Proteins and Receptors (COMPARE), Nottingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
4 University of Würzburg, Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
5 University of Würzburg, Department of Biotechnology and Biophysics, Biocenter, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
6 Endocrinology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy (GRID:grid.414818.0) (ISNI:0000 0004 1757 8749); University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
7 University of Würzburg, Institute for Pharmacology and Toxicology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Würzburg, Bio-Imaging Center/Rudolf Virchow Center, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); Universities of Birmingham and Nottingham, Centre of Membrane Proteins and Receptors (COMPARE), Nottingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)